| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |